news

Shortage of Methyldopa recorded

  • By chagy5
  •   -  
  • 2026-05-01
  • 54
  • 0
Shortage of Methyldopa recorded

A shortage of Methyldopa 250 mg tablets, which is an essential medication used to lower blood pressure, has been reported across both the market and healthcare facilities. As a result, authorities have issued an urgent directive to establish sufficient reserves and restore supply without delay.

Methyldopa is widely used by the public, particularly for managing hypertension, and is included in the national list of essential medicines. It is also provided to patients at a subsidized price through the national health insurance system, making it especially important for accessible and affordable treatment. In addition, the medication is commonly utilized in clinical settings as part of routine healthcare services.

Given the disruption in supply, the state administrative body in charge of control and regulation matters of medicine and medical devices has instructed pharmaceutical suppliers and distributors to urgently secure at least a two-month stock of the medication and ensure its prompt distribution to the market.

According to an official statement issued by the administrative body, regular monitoring is being conducted in cooperation with state-owned healthcare institutions to track shortages and maintain continuity of medical services. The administrative body collects weekly updates on inventory levels and supply gaps in order to coordinate timely responses.

The statement further noted that the current shortage of Methyldopa 250 mg tablets has arisen because the registered importer and distributor are currently unable to provide immediate resupply. In response, the agency has formally reached out to relevant pharmaceutical suppliers within the framework of existing laws and regulatory standards.

Authorities have also emphasized that they will provide full support, within legal provisions, to facilitate the importation of the medication and stabilize its availability. Ensuring uninterrupted access to essential drugs remains a priority, particularly for patients who depend on consistent treatment for chronic conditions such as hypertension.

 

0 COMMENTS